Trevi Therapeutics Correlations
| TRVI Stock | USD 7.00 0.18 2.64% |
The current 90-days correlation between Trevi Therapeutics and Applied Therapeutics is 0.28 (i.e., Modest diversification). The correlation of Trevi Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Trevi Therapeutics Correlation With Market
Modest diversification
The correlation between Trevi Therapeutics and DJI is 0.2 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Trevi Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Moving against Trevi Stock
| 0.33 | T | ATT Inc Earnings Call Today | PairCorr |
| 0.33 | IBM | International Business Earnings Call Today | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Trevi Stock performing well and Trevi Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Trevi Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| APLT | 5.45 | 0.63 | 0.09 | 0.51 | 6.38 | 12.12 | 45.78 | |||
| LYRA | 12.53 | 3.81 | 0.39 | 7.53 | 7.61 | 18.00 | 342.66 | |||
| STTK | 5.06 | 0.06 | 0.02 | 0.21 | 5.58 | 11.11 | 34.28 | |||
| VINC | 6.81 | (3.20) | 0.00 | 710.69 | 0.00 | 8.57 | 64.36 | |||
| BCAB | 4.47 | 0.05 | 0.02 | 0.21 | 4.32 | 12.00 | 34.01 | |||
| KZR | 2.63 | 0.02 | 0.01 | 0.19 | 3.52 | 5.17 | 16.72 | |||
| GRTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| ARDS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| VRCA | 4.77 | 0.59 | 0.11 | 0.64 | 4.62 | 13.21 | 28.86 |
Trevi Therapeutics Corporate Management
| Farrell PharmD | Chief Officer | Profile | |
| Katherine Takaki | Senior Affairs | Profile | |
| Christopher Galletta | Controller Officer | Profile | |
| AFPM MD | Chief Officer | Profile | |
| Danine Summers | Vice Affairs | Profile | |
| Lisa Delfini | Chief Officer | Profile |